2m 2m 2m 2m 2m 2m 2m
Bio-Techne (TECH)
NASDAQ
$72.14+$0.02 (+0.03%)
Price as of Sep 11, 2026 7:30 PM EDT- $11.3BMarket Cap
- 41.49%1-Year Change
- BiotechnologyIndustry
Bio-Techne (TECH)
$72.14+$0.02 (+0.03%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.2B -0.38% | 1.2B +5.23% | 1.2B +1.97% | 1.1B +2.81% | |
Cost of Revenue | 416.0M -3.12% | 429.4M +10.28% | 389.3M +6.12% | 366.9M +5.09% | |
Gross Profit | 799.1M +1.11% | 790.3M +2.67% | 769.7M -0.01% | 769.8M +1.76% | |
Sales and Marketing Expense | 452.4M -23.13% | 588.5M +26.19% | 466.4M +23.26% | 378.4M +1.51% | |
Research and Development Expense | -94.8M -4.75% | -99.5M +2.93% | -96.7M +4.51% | -92.5M +6.14% | |
Depreciation and Amortization Expense | 97.4M -11.41% | 109.9M -1.62% | 111.7M +4.17% | 107.2M +6.10% | |
Total Operating Expenses | 547.2M -20.47% | 688.0M +22.20% | 563.0M +19.57% | 470.9M +2.38% | |
Operating Profit | 251.9M +146.34% | 102.3M -50.53% | 206.7M -30.86% | 298.9M +0.79% | |
Interest Income | 4.2M +8.67% | 3.9M +1,273.14% | 283,000 -93.75% | 4.5M N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -11.2M -0.83% | |
Interest Income and Expense and Net | 4.2M +8.67% | 3.9M +1,273.14% | 283,000 +104.23% | -6.7M -40.85% | |
Total Nonoperating Income and Expense | -11.2M +195.62% | -3.8M -81.94% | -21.0M -152.87% | 39.7M +728.09% | |
Income before Taxes | 240.7M +144.44% | 98.5M -46.97% | 185.7M -45.17% | 338.7M +12.37% | |
Income Taxes | 58.8M +134.68% | 25.1M +42.53% | 17.6M -66.96% | 53.2M +38.99% | |
Extraordinary Items | N/A N/A | 900,000 N/A | N/A N/A | 900,000 0.00% | |
Net Income | 181.9M +147.77% | 73.4M -56.34% | 168.1M -41.07% | 285.3M +4.86% | |
Net Income from Continuing Operations Applicable to Common | 240.7M +144.44% | 98.5M -46.97% | 185.7M -45.17% | 338.7M +12.37% | |
Basic EPS and Net Income | 1.17 +148.94% | 0.47 -56.07% | 1.07 -40.88% | 1.81 -73.88% | |
Diluted EPS and Net Income | 1.16 +152.17% | 0.46 -56.19% | 1.05 -40.34% | 1.76 -73.45% | |
Basic Weighted Average Shares | 156.0M -0.99% | 157.5M -0.12% | 157.7M +0.34% | 157.2M +300.77% | |
Diluted Weighted Average Shares | 157.0M -1.70% | 159.7M -0.66% | 160.8M -0.67% | 161.9M +294.49% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 264.7M +63.22% | 162.2M +6.85% | 151.8M -15.94% | 180.6M +4.64% | |
Short-Term Investments | N/A N/A | 1.1M 0.00% | 1.1M -95.48% | 23.7M -68.12% | |
Cash and Cash Equivalents and Short-Term Investments | 264.7M +62.14% | 163.3M +6.80% | 152.9M -25.18% | 204.3M -17.29% | |
Total Current Assets | 744.4M +22.37% | 608.3M -1.48% | 617.4M -0.65% | 621.5M +2.63% | |
Accumulated Depreciation | 308.3M +7.73% | 286.1M +11.53% | 256.6M +9.77% | 233.7M +10.54% | |
Property and Plant and Equipment and Net | 231.8M -5.65% | 245.7M -2.16% | 251.2M +11.03% | 226.2M +1.33% | |
Total Long-Term Assets | 264.3M -3.39% | 273.6M +3.54% | 264.3M -7.37% | 285.3M +509.26% | |
Total Assets | 2.6B +1.13% | 2.6B -5.40% | 2.7B +2.47% | 2.6B +14.99% | |
Income Taxes Payable | 22.9M +35.20% | 16.9M -71.56% | 59.6M -41.02% | 101.0M -10.00% | |
Total Short-Term Debt | 200.0M -42.20% | 346.0M +8.46% | 319.0M +2,452.00% | 12.5M 0.00% | |
Total Current Liabilities | 163.7M -6.91% | 175.8M +10.33% | 159.4M +24.02% | 128.5M -26.99% | |
Total Long-Term Debt | 200.0M -42.20% | 346.0M +8.46% | 319.0M -8.86% | 350.0M +43.79% | |
Total Long-Term Liabilities | 21.3M -21.18% | 27.1M +105.84% | 13.2M +20.50% | 10.9M -10.79% | |
Total Liabilities | 237.9M -8.45% | 259.8M +5.19% | 247.0M +11.12% | 222.3M -5.07% | |
Retained Earnings | 1.1B +7.33% | 1.1B -19.56% | 1.3B +1.21% | 1.3B +16.61% | |
Total Stockholders Equity | 2.1B +9.87% | 1.9B -7.25% | 2.1B +5.20% | 2.0B +15.56% | |
Total Shares Outstanding | 156.1M +0.72% | 155.0M -2.05% | 158.2M +0.36% | 157.6M +302.56% | |
Cash Flow | |||||
Cash from Operating Activities | 292.1M +1.57% | 287.6M -3.82% | 299.0M +17.53% | 254.4M -21.79% | |
Capital Expenditures | 28.9M -6.95% | 31.0M -50.69% | 62.9M +64.41% | 38.2M -14.84% | |
Cash from Investing Activities | -18.2M -48.30% | -35.2M -82.67% | -203.0M -23.57% | -265.6M +174.29% | |
Dividends Paid | 49.9M -0.94% | 50.4M -0.06% | 50.4M +0.27% | 50.3M +0.20% | |
Cash from Financing Activities | -169.1M -33.39% | -253.9M +107.44% | -122.4M -641.20% | 22.6M +109.31% | |
Financials Ratio | |||||
Gross Margin | 65.77% +1.50% | 64.80% -2.43% | 66.41% -1.94% | 67.72% -1.02% | |
Operating Margin | 20.73% +147.27% | 8.38% -52.98% | 17.83% -32.19% | 26.30% -1.96% | |
Return on Assets | 7.07% +153.41% | 2.79% -55.67% | 6.29% -45.58% | 11.56% -3.13% | |
Return on Equity | 9.03% +145.34% | 3.68% -55.81% | 8.33% -46.43% | 15.55% -6.68% | |
Revenue Growth | -0.38% -107.21% | 5.23% +165.71% | 1.97% -30.08% | 2.81% -85.00% | |
Current Ratio | 4.55 +31.46% | 3.46 -10.70% | 3.87 -19.90% | 4.84 +40.57% | |
Cash Ratio | 1.62 +75.33% | 0.92 -3.16% | 0.95 -32.22% | 1.41 +43.32% | |
Debt-to-Equity Ratio | 0.19 -47.39% | 0.36 +16.93% | 0.31 +67.34% | 0.18 +22.54% | |
Debt-to-Assets Ratio | 0.15 -42.85% | 0.27 +14.62% | 0.24 +71.76% | 0.14 +23.23% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow